Explore our history
-
2020-Present
2023
Awarded Vizient's NovaPlus Top Performer Award
American Regent acquires and then merges with HBT Labs, Inc.
2022
Selenious Acid Injection, USP is launched in a single-dose vial
2021
Multrys® (trace elements injection*, USP) is launched
2020
Tralement® (trace elements injection*, USP), the first FDA-approved trace elements injection is introduced
-
2017-2019
July 2019
Launch of the first and only
FDA-approved Selenious Acid Injection, USPJanuary 2019
American Regent, Inc. merges into Luitpold Pharmaceuticals, Inc. The company name is changed to American Regent.
2018
FDA-approval and launch
of the first preservative free generic Hydroxyprogesterone Caproate Injection, USP2017
American Regent celebrates its 50th Anniversary
-
2006-2016
2016
Launch of ProvayBlue® (methylene blue) Injection, 0.5%, USP*
*ProvayBlue® is a registered trademark of Provepharm Life Solutions, France
2013
Injectafer® (ferric carboxymaltose injection)* is FDA Approved.
*Injectafer® is a registered trademark of Vifor (International) Inc., Switzerland
2009
Luitpold acquires PharmaForce, Inc., broadening its line of generic, multisource injectables.
-
1996-2005
2005
Sankyo merges with
Daiichi Pharmaceutical Company, Ltd.
to become Daiichi-Sankyo Company, Ltd.2002
The name American Regent Laboratories, Inc. was shortened to
American Regent, Inc.2000
Venofer® (iron sucrose injection, USP), now the #1 selling IV iron in the US,* is approved.
*Source: IMS, NSP Audit Dollars & Units 3 year MAT ending January 20171996
American Regent Laboratories introduces Dexferrum® (iron dextran injection, USP).
-
1960s-1995
1991
Sankyo, a Japanese pharmaceutical company, acquires Luitpold and its subsidiary, American Regent Laboratories, Inc.
Mid 1980s
Luitpold Pharmaceuticals, Inc.
acquires American Quinine and transforms the name to
American Regent Laboratories, Inc.1967
A group of dedicated professionals launch our company under the name American Quinine, which provides quality, parenteral products to medical communities within the US and Canada.
Throughout our long history, one thing has been constant—our commitment to ensuring those we serve have the essential medicines they need.
Who We Are
American Regent has a long history. From small beginnings in 1967 as a US-based manufacturer, the company has grown to be one of the leading pharmaceutical companies in the United States. Our growing business is comprised of a mix of branded and generic injectables. For nearly 25 years, we have been the leader in IV iron therapy, supplying the market with the two top-selling brands in the US. For over 40 years, our animal health business has proudly delivered solutions that support the long-term health and well-being of horses and dogs, anchored by two of the leading animal joint health brands.
Our legacy, spanning nearly 60 years, is built on an unwavering commitment to ensuring that the people and animals we serve have the essential medicines they need.
Our Unwavering Purpose
Helping patients live better lives by providing the essential medicines they need is our constant motivation behind everything we do, everyday. To achieve our purpose, our entire organization has dedicated ourselves to our purpose:
Our Mission
To improve human and animal health through the development, manufacturing, and delivery of innovative, accessible, and high-quality sterile injectable products.
Our Vision
Be the leader in supplying and delivering superior quality products that healthcare providers rely on for their patients, with a focus toward fulfilling unmet needs in healthcare by providing industry-leading US manufactured sterile injectables.
Our Core Behaviors
American Regent is on a journey to think, act, and operate with three behaviors that are core to what we stand for:
Be Inclusive & Embrace Diversity: We value people for who they are as individuals, and welcome diverse perspectives in our work, which enables us to achieve more as an organization.
Collaborate & Trust: We treat each other with respect, and build trust through transparency and willingness to listen, which enables us to collaborate simply and productively.
Develop & Grow: We learn, experiment, and take initiative, which enables us to grow together every day, and strengthen our capabilities.
The power of our employees and their collective efforts helps us achieve our goal of contributing to the health and well-being of patients.
Our Four Operating Principles
Speed counts. Flexibility matters. Quality and reliability are paramount. Because patients should never have to wait for the medications they need.
We are committed to setting a higher standard for responsiveness, reliability, and quality. We continue to make significant investments in expanding and modernizing our US-based manufacturing facilities. We have nearly doubled our capacity, created redundancies across our manufacturing sites, and strengthened our expertise in the development of complex drug products and delivery systems.
Taken together, excellence in these four areas looks like a flexible, fast-moving partner. One that is uniquely positioned to quickly respond to and help mitigate shortages or meet changes in market need. A partner committed to delivering essential medications now and well into the future.
Partner with
American Regent
American Regent is a leading manufacturer of generic and branded specialty injectables. Given the dynamics of today’s challenging healthcare marketplace...
The Latest
-
2 Jul 2024
American Regent Introduces Sodium Phosphates Injection, USP; FDA-Approved and “AP” Rated
Shirley, NY – July 2, 2024:
American Regent announces the launch and availability of Sodium Phosphates Injection, USP, which is FDA-approved and therapeutically equivalent to Sodium Phosphates. -
27 Sep 2023
American Regent Receives 2023 Novaplus Program Excellence Award from Vizient
Shirley, NY – September 27, 2023:
American Regent has received a Novaplus Program Excellence Award from Vizient, Inc., the nation’s largest provider-driven health care performance improvement company. The recognition was announced at the 2023 Vizient Connections Summit, held September 18-21 in Las Vegas.
Executive Team
Contact Us
By clicking Submit, you confirm that you accept our Privacy Policy and that you agree to your personal contact information being used to contact you and added to our database. If at any time you wish your personal information to be removed from the American Regent® database, please submit a message request to corpcommunications@americanregent.com.